With budgets shrinking healthcare providers are under greater pressure than ever to deliver value, optimizing procedures and providing cost-and time-efficient care. Point-of-care testing can support this—equipping healthcare professionals with the information they need to make smart, on-the-spot medical decisions that improve workflow efficiency and, ultimately, patient outcomes.
As a leader in health technology, our goal at Philips is to revolutionize healthcare management. Where currently diagnostic blood testing is often carried out in a laboratory setting, we’re innovating to move beyond these walls and bring it near the patient—wherever they need it.
In 2016, we took our first step toward achieving this goal, launching the Minicare I-20 handheld system with cardiac troponin-l (cTnI) assay for suspected heart attack, delivering lab comparable results within just 10 minutes.